Abstract
A double blind clinical trial was carried out in 2 well-matched groups of 20 normal pregnancies ( ≤ 36 weeks) with Pitocin ® and prostaglandin F 2α, administered intravenously in a fixed dose schedule, in order to induce parturition. Uterine contractions and fetal heart rate were recorded. Under the conditions of the set-up no differences in efficacy and the frequency of unwanted side-effects were observed. Prostaglandin F 2α given in this dose schedule was more frequently followed by hypertonia than Pitocin ®.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call